Syphilis Immunoassay Diagnostics Market 2024: A Deep Dive into Global Industry Trends, Key Drivers, and Technological Advancements

The new report published by The Business Research Company, titled "Syphilis Immunoassay Diagnostics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the syphilis immunoassay diagnostics market size has grown strongly in recent years. It will grow from $29.08 billion in 2023 to $31.25 billion in 2024 at a compound annual growth rate (CAGR) of 7.5%. The syphilis immunoassay diagnostics market size is expected to see strong growth in the next few years. It will grow to $42.17 billion in 2028 at a compound annual growth rate (CAGR) of 7.8%.

Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16806&type=smp

Rising Sexually Transmitted Diseases Boosting Syphilis Immunoassay Diagnostics Market
The rise in sexually transmitted diseases is expected to propel the growth of the syphilis immunoassay diagnostics market going forward. Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs), are infections that are primarily spread through sexual contact. It includes vaginal, anal. The rise in sexually transmitted diseases is attributed to decreasing use, antibiotic resistance, lack of sexual education, social and behavioral changes, stigma, reduced funding for STD programs, and increased travel. Syphilis immunoassay diagnostics help in the detection and management of sexually transmitted diseases by providing accurate, timely identification of syphilis infection, enabling appropriate treatment and prevention measures. For instance, in January 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government agency, around 2.54 million cases of sexually transmitted diseases were recorded in 2021, up from 2.4 million in 2020. Therefore, the rise in sexually transmitted diseases is driving the syphilis immunoassay diagnostics market.

Advancements In Rapid Syphilis Immunoassay Diagnostics
Major companies operating in the syphilis immunoassay diagnostics market are focused on developing innovative solutions, such as rapid syphilis tests, to enhance the efficiency and accuracy of syphilis detection. Rapid syphilis tests are simple, point-of-care tools that detect syphilis antibodies in blood or bodily fluids within minutes, enabling quick diagnosis and early treatment. For instance, in February 2023, Chembio Diagnostics Inc., a US-based point-of-care diagnostics company focused on infectious diseases, received a CLIA waiver from the FDA for its DPP HIV-Syphilis System. The DPP HIV-Syphilis System is a dual rapid test designed for the simultaneous detection of antibodies to HIV 1/2 and Treponema pallidum, the bacteria that causes syphilis. This rapid, 15-minute test aims to improve diagnosis and treatment, especially in preventing mother-to-child transmission of syphilis and reducing the risk of contracting HIV among those with syphilis.

The syphilis immunoassay diagnostics market covered in this report is segmented -

1) By Product: Analyzers, Reagents, Kits, Other Products
2) By Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Other Technologies
3) By Application: Men, Women
4) By End-User: Hospitals, Blood Banks, Diagnostics Labs, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16806&type=discount

Major companies operating in the syphilis immunoassay diagnostics market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Becton Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories Inc., Meril Life Sciences Pvt. Ltd., Randox Laboratories Ltd., SEKISUI Diagnostics, Bloodworks Northwest, LetsGetChecked, Everlywell Inc., ACON Laboratories Inc., Trinity Biotech, Fujirebio, CTK Biotech Inc., bioLytical Laboratories Inc., AdvaCare Pharma, MyBioSource.com, Gold Standard Diagnostics Frankfurt GmbH , Newmarket Biomedical Ltd, InTec PRODUCTS INC.,

Contents of the report:
1. Executive Summary
2. Syphilis Immunoassay Diagnostics Market Report Structure
3. Syphilis Immunoassay Diagnostics Market Trends And Strategies
4. Syphilis Immunoassay Diagnostics Market - Macro Economic Scenario
5. Syphilis Immunoassay Diagnostics Market Size And Growth
…..
27. Syphilis Immunoassay Diagnostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/syphilis-immunoassay-diagnostics-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.